The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis

NCT05813561 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

332

Enrollment

INDUSTRY

Sponsor class

Conditions

Reflux Esophagitis

Interventions

DRUG: DWP14012

Sponsor

Daewoong Pharmaceutical Co. LTD.